United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News FDA clears Servier and Pfizer for clinical development of UCART19 for acute lymphoblastic leukemia Servier and Pfizer Inc. have received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration… bypharmanewsdailyMarch 12, 2017
